Danaher Corporation Stock: A Good Medium Term Bet (NYSE:DHR)

blackred Investment Thesis Danaher Corporation’s (NYSE:DHR) core sales growth rate is expected to turn positive as 2024 progresses, with customer inventory destocking ending by the second half of 2024 in the bioprocessing business and improving order trends in the Biotechnology and Life Sciences segments. Further, the strength in the Diagnostics segment and easier Chinese business…

Read More